Literature DB >> 33839785

Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients - a prospectivecohort study.

Timna Agur1,2, Naomi Ben-Dor1,2, Shira Goldman1,2, Shelly Lichtenberg1,2, Michal Herman-Edelstein1,2, Dafna Yahav2,3, Benaya Rozen-Zvi1,2, Boris Zingerman1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33839785      PMCID： PMC8083335          DOI： 10.1093/ndt/gfab155

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  40 in total

1.  Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.

Authors:  Caroline M Hsu; Daniel E Weiner; Harold J Manley; Gideon N Aweh; Vladimir Ladik; Jill Frament; Dana Miskulin; Christos Argyropoulos; Kenneth Abreo; Andrew Chin; Reginald Gladish; Loay Salman; Doug Johnson; Eduardo K Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-10       Impact factor: 8.237

2.  Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients.

Authors:  Michael Paal; Florian M Arend; Tobias Lau; Sandra Hasmann; Daniela Soreth-Rieke; Johanna Sorodoc-Otto; Wilke Beuthien; Julia Krappe; Marcell Toepfer; Gero von Gersdorff; Norbert Thaller; Simon Rau; Bernd Northoff; Daniel Teupser; Mathias Bruegel; Michael Fischereder; Ulf Schönermarck
Journal:  Clin Kidney J       Date:  2021-07-06

Review 3.  Immune responses to SARS-CoV-2 in dialysis and kidney transplantation.

Authors:  Chiara Cantarelli; Andrea Angeletti; Laura Perin; Luis Sanchez Russo; Gianmarco Sabiu; Manuel Alfredo Podestà; Paolo Cravedi
Journal:  Clin Kidney J       Date:  2022-07-27

Review 4.  Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity.

Authors:  Bart N Ford; Jonathan Savitz
Journal:  Immun Ageing       Date:  2022-07-14       Impact factor: 9.701

5.  Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.

Authors:  Moshe Shashar; Naomi Nacasch; Ayelet Grupper; Sydney Benchetrit; Tamar Halperin; Daniel Erez; Ilan Rozenberg; Pnina Shitrit; Yaron Sela; Ori Wand; Keren Cohen-Hagai
Journal:  Am J Nephrol       Date:  2022-02-16       Impact factor: 4.605

6.  Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis.

Authors:  Kuei-Ting Tung; Yu-Sen Peng; Shih-Ping Hsu; Hon-Yen Wu; Yen-Ling Chiu; Ju-Yeh Yang; Mei-Fen Pai; Kai-Hsiang Shu; Szu-Yu Pan; Hui-Ming Lu; Wan-Yu Lin; Chun-Hsing Liao; Fang-Yeh Chu; Wan-Chuan Tsai
Journal:  Hemodial Int       Date:  2022-04-11       Impact factor: 1.543

7.  BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel.

Authors:  Tal Brosh-Nissimov; Efrat Orenbuch-Harroch; Michal Chowers; Meital Elbaz; Lior Nesher; Michal Stein; Yasmin Maor; Regev Cohen; Khetam Hussein; Miriam Weinberger; Oren Zimhony; Bibiana Chazan; Ronza Najjar; Hiba Zayyad; Galia Rahav; Yonit Wiener-Well
Journal:  Clin Microbiol Infect       Date:  2021-07-07       Impact factor: 8.067

8.  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.

Authors:  Edward J Carr; Andreas Kronbichler; Matthew Graham-Brown; Graham Abra; Christos Argyropoulos; Lorraine Harper; Edgar V Lerma; Rita S Suri; Joel Topf; Michelle Willicombe; Swapnil Hiremath
Journal:  Kidney Int Rep       Date:  2021-07-06

9.  The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.

Authors:  Emanuel Zitt; Tamara Davidovic; Judith Schimpf; Armin Abbassi-Nik; Beatrix Mutschlechner; Hanno Ulmer; Magdalena A Benda; Hannelore Sprenger-Mähr; Thomas Winder; Karl Lhotta
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

10.  Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.

Authors:  José Jesús Broseta; Diana Rodríguez-Espinosa; Néstor Rodríguez; María Del Mar Mosquera; María Ángeles Marcos; Natalia Egri; Mariona Pascal; Erica Soruco; José Luis Bedini; Beatriu Bayés; Francisco Maduell
Journal:  Am J Kidney Dis       Date:  2021-06-24       Impact factor: 8.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.